FDA Warns Novo for Second Time About Misleading Ozempic Advertising

The U.S. Food and Drug Administration has warned ‌Novo Nordisk over a consumer ad for its blockbuster diabetes drug, Ozempic, saying the commercial makes ‌false and misleading claims about the drug’s ⁠benefits. It is the second time in less than a month that the FDA has warned the Danish drugmaker about its misleading ​ads. The […]